ENZO BIOCHEM INC (ENZB) Insider Trading & SEC Filings

Updated Jul 16, 2026 · Last SEC filing 2025-08-20

ENZO BIOCHEM INC (ENZB) — no SEC Form 4 insider filings recorded in the last 90 days. InsiderAlpha tracks every ENZB SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.

About ENZO BIOCHEM INC (ENZB)

SEC CIK	0000316253

Recent ENZB Insider Transactions (Form 4)

Date	Insider	Role	Transaction	Shares	Price	Value	Filing
2025-08-20	PULLY STEVEN J	Director	D — Derivative transaction	240.0K	—	—	SEC
2025-08-20	COUCHMAN JONATHAN	Director	D — Derivative transaction	142.9K	—	—	SEC
2025-08-20	COUCHMAN JONATHAN	Director	D — Derivative transaction	130.0K	—	—	SEC
2025-08-20	COUCHMAN JONATHAN	Director	D — Derivative transaction	40.0K	—	—	SEC
2025-08-20	COUCHMAN JONATHAN	Director	D — Derivative transaction	15.0K	—	—	SEC
2025-08-20	COUCHMAN JONATHAN	Director	D — Derivative transaction	277.2K	—	—	SEC
2025-08-20	Radoff Bradley Louis	Director	D — Derivative transaction	4.53M	—	—	SEC
2025-08-20	Radoff Bradley Louis	Director	D — Derivative transaction	430.0K	—	—	SEC
2025-08-20	Cannon Kara	Chief Executive Officer	D — Derivative transaction	359.7K	—	—	SEC
2025-08-20	Cannon Kara	Chief Executive Officer	D — Derivative transaction	45.1K	—	—	SEC
2025-08-20	Eckert Patricia	Chief Financial Officer	D — Derivative transaction	28.3K	—	—	SEC

All transactions sourced from SEC EDGAR Form 4 filings for ENZO BIOCHEM INC (ENZB). Updated in real time as new filings are submitted to the SEC.

Recent Insider Filings

2025-08-20 — PULLY STEVEN J (Director)
2025-08-20 — COUCHMAN JONATHAN (Director)
2025-08-20 — Radoff Bradley Louis (Director)
2025-08-20 — Cannon Kara (Chief Executive Officer)
2025-08-20 — Eckert Patricia (Chief Financial Officer)

Form 4 Transaction Code Reference

SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in ENZB insider filings:

P	Open-market purchase by the insider
S	Open-market sale by the insider
A	Grant, award, or other acquisition from the issuer
M	Exercise or conversion of derivative security (e.g. options)
F	Payment of exercise price or tax liability via share withholding
G	Bona-fide gift of securities
D	Disposition to the issuer (e.g. share buyback participation)
J	Other acquisition or disposition
X	Exercise of in-the-money or at-the-money derivative security
C	Conversion of derivative security
V	Transaction voluntarily reported earlier than required

ENZB Insider Trading — FAQ

What is the latest insider trade for ENZB?: ENZO BIOCHEM INC (ENZB) had 0 insider filings in the last 90 days, with the most recent on 2025-08-20. InsiderAlpha tracks every Form 4, 10-K, 10-Q, and 8-K filing in real time.
How many insiders are buying ENZB stock?: 0 insider purchases of ENZB were filed in the last 90 days.
How many insiders are selling ENZB stock?: 0 insider sales of ENZB were filed in the last 90 days.
Where can I see ENZB SEC filings (Form 4, 10-K, 10-Q, 8-K)?: InsiderAlpha aggregates every ENZB SEC filing — Form 4 insider transactions, 10-K and 10-Q quarterly reports, and 8-K material event disclosures — in one timeline.

Learn More

Open the live ENZB dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.